Published in Int Urol Nephrol on January 01, 1989
[Capillary electrophoresis coupled to mass spectrometry for proteome analysis. An innovative diagnostic method for prostate and bladder cancer]. Urologe A (2007) 1.38
Inheritance and testicular cancer. Arguments based on a report of 3 cases and a review of the literature. Oncology (1987) 1.25
Psychoneuroimmunological correlates of persisting sciatic pain in patients who underwent discectomy. Neurosci Lett (1997) 1.22
Bilateral testicular germ cell tumors. Report of nine cases and review of the literature. Cancer (1986) 1.09
Adrenal myelolipoma: clinical, radiologic, and histologic features. Urology (1987) 0.99
Intrascrotal metastasis of renal cell carcinoma. Case reports and review of the literature. Eur Urol (1988) 0.97
Detection of sensitized human blood lymphocytes by agglutination with basic peptides: a possible test for malignant disease. Br J Cancer (1977) 0.95
Testicular tumors: presentation and role of diagnostic delay. Urol Int (1987) 0.92
[Correlation of alpha-2 pregnancy associated glycoprotein with the clinical course of bronchial carcinoma (author's transl)]. Thoraxchir Vask Chir (1977) 0.92
[European Association of Urology guidelines on urinary and male genital tract infections]. Urologe A (2003) 0.89
Recombinant interferon alfa-2a with or without vinblastine in metastatic renal cell carcinoma: results of a European multi-center phase III study. Ann Oncol (1992) 0.87
Enzymes of androgen formation and degradation in the human prostate. Ann N Y Acad Sci (1990) 0.86
[Primary and secondary prevention of urinary tract infections]. Urologe A (2011) 0.83
Prevention of recurrent urinary tract infections. Minerva Urol Nefrol (2013) 0.82
Seminoma testis and concomitant ipsilateral renal cell carcinoma. Urol Int (1988) 0.81
Evaluation of the cytotoxic activity of diethylstilbestrol and its mono- and diphosphate towards prostatic carcinoma cells. Cancer Res (1988) 0.81
Steroid receptors and proliferative activity in non-neoplastic and neoplastic endometria. Virchows Arch A Pathol Anat Histopathol (1990) 0.80
[Pregnancy-specific and pregnancy-associated proteins for diagnosing and monitoring malignant disease (author's transl)]. Klin Wochenschr (1978) 0.79
Carcinoembryonic antigen, alpha 1-fetoprotein, ferritin, and alpha 2-pregnancy associated glycoprotein in the serum of lung cancer patients and its demonstration in lung tumor tissues. Oncology (1977) 0.79
The PAL test for malignant disease in man. Br J Cancer (1978) 0.79
Steroid hormone regulation of prostatic acid phosphatase expression in cultured human prostatic carcinoma cells. Biol Chem Hoppe Seyler (1985) 0.79
Testicular seminoma in an immunosuppressed renal transplant recipient. Br J Urol (1989) 0.79
Immunostimulation by bacterial components: II. Efficacy studies and meta-analysis of the bacterial extract OM-89. Int J Immunopharmacol (2000) 0.78
[Failure following fertility vasectomy]. Med Welt (1980) 0.78
[The significance of determining intermediate filament and epithelial membrane antigens in the differential diagnosis and histogenetic differentiation of ovarian tumors]. Verh Dtsch Ges Pathol (1986) 0.78
[Pregnancy associated alpha2-glycoprotein (alpha2-PAG) in the serum of patients with gynecologic carcinomas]. Onkologie (1978) 0.76
[Coexpression of cytokeratin, desmin, and neurofilaments in malignant tumors]. Verh Dtsch Ges Pathol (1988) 0.76
Surgical correction of rectoprostatic fistula. Urology (1984) 0.76
Simultaneous bilateral testicular germ cell tumors with dissimilar histology. Case report and review of the literature. Urol Int (1988) 0.76
[Significance of postoperative substitution of plasma proteins]. Infusionsther Klin Ernahr (1980) 0.75
A new technique for percutaneous nephropyelostomy. J Urol (1981) 0.75
[Determination of depth of infiltration of of vesical tumors by intravesical ultrasonic tomography (author's transl)]. MMW Munch Med Wochenschr (1980) 0.75
[Pregnancy,-associated alpha 2-glycoprotein (alpha 2-PAG): a possible marker for tumor monitoring?]. Onkologie (1980) 0.75
Prophylaxis of complications after urological abdominal surgery by substitution of plasma proteins. J Surg Oncol (1986) 0.75
The pregnancy-associated alpha 2-glycoprotein (alpha 2-PAG). A tumour marker? Klin Wochenschr (1981) 0.75
[Operative management of spontaneous kidney transplant rupture. Personal experiences and literature review]. Chirurg (1982) 0.75
[Determination of acid phosphatase in prostatic carcinoma]. Fortschr Med (1980) 0.75
[Traffic fraction of emissions of total dust and polycyclic aromatic hydrocarbons in large German cities]. Schriftenr Ver Wasser Boden Lufthyg (1986) 0.75
[Antegrade fine needle pyelography of transplanted kidneys]. Fortschr Med (1984) 0.75
[Aminoglutethimide in the treatment of advanced prostatic cancer]. Urologe A (1985) 0.75
Intravesical ultrasound tomography in staging bladder carcinoma. J Urol (1982) 0.75
[Early diagnosis in testicular tumors. Results of a survey]. Med Klin (Munich) (1987) 0.75
[Reactive benign thymus hyperplasia following cytostatic chemotherapy]. Dtsch Med Wochenschr (1988) 0.75
[Diagnosis and follow-up of prostatic cancer using an enzyme immunoassay for prostate-specific acid phosphatase]. Helv Chir Acta (1981) 0.75
[In vivo study of the effects of i.v. immunoglobulin therapy. Tissue distribution of native and enzyme-treated human immunoglobulin fractions given i.v. in man]. Fortschr Med (1979) 0.75
[Adrenal myelolipoma. Clinical aspects, diagnosis and therapy]. Med Klin (Munich) (1986) 0.75
Carcinoma-in-situ of testis in patients with assumed extragonadal germ-cell tumours. Lancet (1987) 0.75
[Immunochemical measurement of prostatic acid phosphatase in carcinoma of the prostate]. Ric Clin Lab (1984) 0.75
[Familial testicular tumors. Arguments for the effect of genetic factors]. Med Klin (Munich) (1986) 0.75
[Intravesical ultrasound tomography of bladder wall changes (author's transl)]. Urologe A (1981) 0.75
[Prostaglandin E2 in prostatitis and prostatic adenoma]. Urol Int (1986) 0.75
[Immunologic potency of pregnancy associated alpha 2-glycoprotein (alpha 2-PAG)]. Onkologie (1978) 0.75
[The Lasix sonogram for the functional elucidation of ureteral outflow obstruction]. Helv Chir Acta (1986) 0.75
[Prevention of complications following abdominal surgical urologic interventions by plasma protein substitutes]. Infusionsther Klin Ernahr (1984) 0.75
[Pregnancy-associated alpha 2-glycoprotein (importance of its determination in malignant tumors)]. Ric Clin Lab (1981) 0.75
Pregnancy associated alpha2-glycoprotein in malignant melanoma. Eur J Cancer (1979) 0.75
[Diagnosis of malignant processes of the colon and rectum using a new method for the demonstration of sensitized lymphocytes (PAL-test)]. Chir Forum Exp Klin Forsch (1978) 0.75
[Medicinal plants--increased importance in the framework of conservative therapy]. Fortschr Med Monogr (1991) 0.75
[Significance of an immunoenzyme assay of the prostate-specific acid phosphatase (PAP) (E.C.3.1.3.2.) in prostatic carcinoma. Methods and initial clinical results]. Urologe A (1983) 0.75
Clinical assessment of solid phase immunoadsorbent assay of human prostatic acid phosphatase. Urology (1984) 0.75
[A new method for the detection of sensitized lymphocytes in malignant diseases--PAL test]. Verh Dtsch Ges Inn Med (1978) 0.75
[Immunological demonstration of estrogen and progesterone receptors in testicular Leydig cell tumors]. Verh Dtsch Ges Pathol (1988) 0.75
[MD-KOVA system for analysis of urine sediments]. Med Lab (Stuttg) (1982) 0.75
[Surgical correction of prostato-rectal fistulas]. Urologe A (1983) 0.75
[Bilateral stage nephrectomy as a preparation for kidney transplantation]. Fortschr Med (1982) 0.75
Enzyme immunoassay for the prostate-specific acid phosphatase (E. C. 3.1.3.2). Urol Res (1981) 0.75
Variations in the level of the pregnancy-associated alpha 2-glycoprotein in patients with gynaecologic cancer. Eur J Cancer (1980) 0.75
[Organizational and technical aspects of organ removal]. Urologe A (1982) 0.75
[Examination of urine sediment using the MD-Kova system]. Med Welt (1982) 0.75
PAL-test for malignant disease. Z Krebsforsch Klin Onkol Cancer Res Clin Oncol (1978) 0.75
[Pregnancy-associated alpha2-glycoprotein levels in patients with lung cancer (author's transl)]. Prax Klin Pneumol (1978) 0.75
[Serologic breast cancer follow-up monitoring using pregnancy-associated alpha-2-glycoproteins]. Chir Forum Exp Klin Forsch (1977) 0.75
[Perineal ectopic testis]. Urologe A (1988) 0.75
[Immunoenzyme assay for prostate-specific acid phosphatase in prostatic cancer]. Med Welt (1982) 0.75
Simultaneous bilateral germ cell tumors of the testicles. Case reports and review of the literature. Eur Urol (1985) 0.75
Circadian variation of different fractions of serum acid phosphatase. Prostate (1983) 0.75